Balancing Benefits and Risks in Patients Receiving Incretin-Based Therapies: Focus on Cardiovascular and Pancreatic Side Effects
Crossref DOI link: https://doi.org/10.1007/s40264-014-0238-8
Published Online: 2014-11-13
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Haluzík, Martin
Mráz, Miloš
Svačina, Štěpán
Text and Data Mining valid from 2014-11-13
